Abstract
The disturbance in menstrual bleeding induced by many methods of contraception is an important side-effect because of its potential impact on acceptability. Amenorrhea tends to be rejected because most women value menstruation as an assurance that they are not pregnant; it is also indicative of femininity, fertility and continuing youth, and widely viewed as important to general well-being1. Prolonged or unpredictable bleeding may, at best, be merely inconvenient or embarrassing, but in some cultures the taboos associated with menstruation can make any disruption to the normal pattern almost intolerable. As many as 25% of women recruited to trials of the long-acting injectable, depot medroxypro-gesterone acetate (DMPA), discontinue method use within a year because of bleeding problems.2,3 In recent studies of newer methods, the one-year cumulative discontinuation rates for bleeding irregularities have ranged from 9% among women using monthly injectables to 17% in a group using a vaginal ring.4,5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Snowden R, Christian B, (eds). Patterns and Perceptions of Menstruation. Croom Helm, London. 1983.
World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. A multicenterd Phase III comparative clinical trial of depot medroxyprogesterone acetate given three-monthly at doses of 100mg or 150mg: 1. Contraceptive efficacy and side effects. Contraception 34:223–235. 1986.
WHO Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Long-Acting Agents for the Regulation of Fertility. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception 28:1–20. 1983.
World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. A multicenterd Phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. Contraception 37:1–20. 1988.
WHO Task Force on Long-Acting Systemic Agents for Fertility Regulation. Microdose intravaginal levonorgestrel contraception: a multicenter clinical trial. I. Contraceptive efficacy and side-effects. Contraception 41:105–124. 1990.
WHO Task Force on Acceptability of Fertility Regulating Methods (Section on Patterns and Perceptions of Menstrual Bleeding). Report on a meeting on the statistical analysis of menstrual bleeding data. Geneva, 27–29 October 1975, (unpublished).
Belsey EM, Machin D, d’Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 34:253–260. 1986.
Belsey EM, Peregoudov S, Task Force on Long-Acting Systemic Agents for Fertility Regulation. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations. Contraception 38:227–242. 1988.
Arnt IC, et. al. Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel-ethinyl estradiol ratios. Fertil Steril 28:549–553. 1977.
Larranaga A, et. al. Clinical evaluation of two biphasic and one triphasic norgestral/ethinyl estradiol regimens. Int J Fertil 23:193–199. 1978.
Rubio B, Mischler TW, Berman E. Further experience with a once-a-month oral contraceptive: quinestrol-quingestanol. Fertil Steril 23:734–738. 1972.
Vessey MP, et. al. Randomised double-blind trial of four oral progestagen-only contraceptives. Lancet 1:915–922. 1972.
Apelo R, Veloso I. Clinical experience with ethinyl estradiol and d-norgestrel as an oral contraceptive. Fertil Steril 26:283–288. 1975.
Ferrari A, et. al. The menstrual cycle in women treated with d-norgestrel 37.5 micrograms in continuous administration. Int J Fertil 18:133–140. 1973.
Tejuja S, et. al. Experience with 50 meg and 75 meg dl-norgestrel as a mini-pill in India. Contraception 10:385–394. 1974.
Prsic J, Kicovic PM. Low-dose lynestrenol as a contraceptive method. Contraception 8:315–326. 1973.
The International Committee for Contraception Research of the Population Council. Contraception with long acting subdermal implants: I. An effective and acceptable modality in international clinical trials. Contraception 18:315–333. 1978.
The International Committee for Contraception Research of the Population Council. Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials. Contraception 18:335–353. 1978.
Faundes A, Sivin I, Stern J. Long acting contraceptive implants. An analysis of menstrual bleeding patterns. Contraception 18:355–365. 1978.
Sivin I, et. al. Three-year experience with NORPLANT™ subdermal contraception. Fertil Steril 39:799–808. 1983.
Sivin I, et. al. A four-year clinical study of NORPLANTR implants. Stud Fam Plann 14:184–191. 1983.
Sivin I, et. al. Norplant: reversible implant contraception. Stud Fam Plann 11:227–235. 1980.
Alvarez F, et. al. Comparative clinical trial of the progestins R-2323 and levonorgestrel administered by subdermal implants. Contraception 18:151–162. 1978.
Diaz S, et. al. A five-year clinical trial of levonorgestrel silastic implants (Norplant™). Contraception 25:447–456. 1982.
Shaaban MM, et. al. A prospective study of NORPLANTR implants and the TCu 380Ag IUD in Assiut, Egypt. Stud Fam Plann 14:163–169. 1983.
Satayapan S, Kanchanasinith K, Varakamin S. Perceptions and acceptability of NORPLANTR implants in Thailand. Stud Fam Plann 14:170–176. 1983.
Lubis F, et. al. One-year experience with NORPLANTR implants in Indonesia. Stud Fam Plann 14:181–184. 1983.
Belsey EM, Task Force on Long-Acting Systemic Agents for Fertility Regulation. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38:207–225. 1988.
Belsey EM, Carlson N. The description of menstrual bleeding patterns: towards fewer measures. Statistics in Medicine, 10:267–284. 1991.
Treloar AE, et. al. Variation of the human menstrual cycle through reproductive life. Int J Fertil 12:77–126. 1967.
Chiazze L, et. al. The length and variability of the human menstrual cycle. JAMA 203:377–380. 1968.
Mayes DG, Harding CM. The statistical analysis of menstrual bleeding patterns. Report of WHO Project 77084, (unpublished).
Bernstein L, et. al. The effects of moderate physical activity on menstrual cycle patterns in adolescence: Implications for breast cancer prevention. Br J Cancer 55:681–685. 1987.
Ovellette MD, MacVicar MG, Harlan G. Relationship between percent body fat and menstrual patterns in athletes and non-athletes. Nurs Res 35:330–333. 1986.
Belsey EM et. al. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. The influence of individual characteristics. Contraception 38:243–257. 1988.
WHO Special Programme of Research, Development and Research Training in Human Reprodunton; Task Force on Long-Acting Systemic Agents for the Regulation of Fertility. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects. Contraception 17:395–406. 1978.
Sivin I. International experience with NorplantR and NorplantR-2 contraceptives. Stud Fam Plann 19:81–94. 1988.
WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives. A randomized, double-blind study of six combined oral contraceptives. Contraception 25:231–241. 1982.
WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives. Contraception 25:243–252. 1982.
Rodriguez G, Faundes-Latham A, Atkinson LE. An approach to the analysis of menstrual patterns in the critical evaluation of contraceptives. Stud Fam Plann 7:42–51. 1976.
Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47: 583–621. 1952.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Plenum Press, New York
About this chapter
Cite this chapter
Belsey, E.M. (1994). Regional and Individual Variation in Bleeding Patterns Associated with Steroid Contraception. In: Snow, R., Hall, P. (eds) Steroid Contraceptives and Women’s Response. Reproductive Biology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2445-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2445-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44718-1
Online ISBN: 978-1-4615-2445-8
eBook Packages: Springer Book Archive